Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah A Valantine

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Current Opinion in Infectious Diseases|July 5, 2007
Cytomegalovirus-associated allograft rejection in heart transplant patientsLuciano Potena, Hannah A Valantine
Science (New York, N.Y.)|March 14, 2020
NIH progress toward inclusive excellenceHannah A Valantine, Francis Collins
Circulation|July 17, 2023
The Time to Act Is Now: Racial Disparities After Heart TransplantationKiran K Khush, Hannah A Valantine
Expert Opinion on Emerging Drugs|March 7, 2009
New developments in immunosuppressive therapy for heart transplantationKiran K Khush, Hannah A Valantine
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
National Institutes of Health addresses the science of diversityHannah A Valantine, Francis S Collins
JACC. Heart Failure|July 3, 2024
Toward Equitable Heart Transplant Outcomes: Interrupting Danger Signals to Define New Therapeutic StrategiesHannah A Valantine, Kiran K Khush
Circulation|November 1, 2021
Can We Predict Rejection Early After Heart Transplantation?William F Fearon, Hannah A Valantine
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Transcriptomics in transplantation: More than just biomarkers of allograft rejectionPalak Shah, Hannah A Valantine, Sean Agbor-Enoh
CBE Life Sciences Education|September 3, 2016
From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research WorkforceHannah A Valantine, P Kay Lund, Alison E Gammie
Transplantation|December 14, 2006
Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: impact of acute disease versus subclinical infectionMargaret E Cooke, Luciano Potena, Helen Luikart, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Current Opinion in Infectious Diseases|July 5, 2007
Cytomegalovirus-associated allograft rejection in heart transplant patientsLuciano Potena, Hannah A Valantine
Science (New York, N.Y.)|March 14, 2020
NIH progress toward inclusive excellenceHannah A Valantine, Francis Collins
Circulation|July 17, 2023
The Time to Act Is Now: Racial Disparities After Heart TransplantationKiran K Khush, Hannah A Valantine
Expert Opinion on Emerging Drugs|March 7, 2009
New developments in immunosuppressive therapy for heart transplantationKiran K Khush, Hannah A Valantine
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2015
National Institutes of Health addresses the science of diversityHannah A Valantine, Francis S Collins
JACC. Heart Failure|July 3, 2024
Toward Equitable Heart Transplant Outcomes: Interrupting Danger Signals to Define New Therapeutic StrategiesHannah A Valantine, Kiran K Khush
Circulation|November 1, 2021
Can We Predict Rejection Early After Heart Transplantation?William F Fearon, Hannah A Valantine
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Transcriptomics in transplantation: More than just biomarkers of allograft rejectionPalak Shah, Hannah A Valantine, Sean Agbor-Enoh
CBE Life Sciences Education|September 3, 2016
From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research WorkforceHannah A Valantine, P Kay Lund, Alison E Gammie
Transplantation|December 14, 2006
Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: impact of acute disease versus subclinical infectionMargaret E Cooke, Luciano Potena, Helen Luikart, et al.
Pageof 9